FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1948-1950 May 12, 2005 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Ramaekers, V. T. PubMed Citation

In 1904, a little more than a century ago, Julius Donath, a senior physician working in the Vienna Merchants' Hospital, and Karl Landsteiner, the chair of the pathology department at the University of Vienna and one of the founders of immunochemistry, reported the first known autoimmune disease in humans, paroxysmal cold hemoglobinuria. They showed that an antibody in this disease reacted in the cold with the patient's own erythrocytes. By definition, the Donath–Landsteiner antibody was an autoantibody. This revolutionary discovery flew in the face of "horror autotoxicus," a principle that Paul Ehrlich had expounded after failing to find autoantibodies in . . . [Full Text of this Article]

Source Information

Dr. Schwartz is a deputy editor of the Journal.

This article has been cited by other articles:

• Knutson, K. L., Krco, C. J., Erskine, C. L., Goodman, K., Kelemen, L. E., Wettstein, P. J., Low, P. S., Hartmann, L. C., Kalli, K. R. (2006). T-Cell Immunity to the Folate Receptor Alpha Is Prevalent in Women With Breast or Ovarian Cancer. JCO 24: 4254-4261 [Abstract] [Full Text]